Beneficient Gets Nasdaq Notice Over $35 Million Market Value Rule
Beneficient said Nasdaq notified it on Nov. 5, 2026 that its listed securities' market value fell below the $35 million minimum for 30 straight business days; it has until May 4, 2027 to regain compliance.
What happened
Beneficient, a Dallas-based financial services company whose Class A common stock trades on the Nasdaq Capital Market under the ticker BENF, disclosed in a Form 8-K filed Nov. 12, 2026 that it received a notice from Nasdaq's Listing Qualifications Department dated Nov. 5, 2026.
According to the filing, the market value of the company's listed securities was below $35 million for the 30 consecutive business days from Sept. 24, 2026 through Nov. 4, 2026. That is the minimum required to stay listed on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2).
The notice also said Beneficient does not meet the alternative continued listing standards under Nasdaq rules 5550(b)(1) and 5550(b)(3), which concern minimum stockholders' equity and net income from continuing operations, respectively.
The company said the notice has no immediate effect on the listing or trading of its Class A common stock or its warrants, which continue to trade under BENF and BENFW. Beneficient's shares closed at $0.681 on the report date, down 3.27% from the prior close of $0.704, according to the price data.
The compliance window
Under Nasdaq Listing Rule 5810(c)(3)(C), Beneficient has an initial 180-calendar-day period, running to May 4, 2027, to regain compliance with the market value requirement.
The filing states that if the company's listed-securities market value closes at $35 million or more for at least ten consecutive business days at any point before that date, Nasdaq will confirm compliance in writing and close the matter. Nasdaq may, at its discretion, require a longer streak — generally no more than 20 consecutive business days — before making that determination.
If Beneficient has not regained compliance by May 4, 2027, Nasdaq will notify the company that its securities are subject to delisting. The company could then appeal to a Nasdaq Hearings Panel.
Beneficient said it intends to monitor its market value and is evaluating options to regain compliance, but that there is no assurance it will do so in time. The filing does not say what specific steps the company is considering, and it does not state a reason why the market value fell below the threshold.
What this means
A Form 8-K is the report a U.S. public company files with the SEC to disclose material events between its regular quarterly and annual reports. Item 3.01, the item cited here, is specifically for notice of a delisting or a failure to meet a continued listing rule — in this case, a warning from the exchange rather than an actual removal.
The rule at issue is a market-value test rather than a share-price test. Nasdaq's $35 million minimum for the Capital Market tier measures the total value of all of a company's listed securities — shares and warrants together — not the price of a single share. Because that figure is share price multiplied by shares and warrants outstanding, a low stock price can pull a company under the threshold even if its share count has not changed.
That distinction matters for Beneficient because its stock closed at $0.681, a level at which the company needs a large number of shares outstanding to clear $35 million. The filing does not break out the share and warrant counts or the market value at the time of the notice, so the size of the gap is not disclosed.
The 180-day period is a standard cure window that Nasdaq grants under its rules; the company does not have to do anything to start it. What normally happens next is that the company either trades back above the threshold for the required streak and Nasdaq closes the matter, or the window expires and a delisting notice follows, which the company can appeal. The filing does not predict which path will occur.
Sources
- 8-K filed 2026-11-12
- Daily price history
Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.